Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Cancer Vaccine Platform Uses COVID-19 Immune Memory to Fight Tumors
12+ hour, 36+ min ago (345+ words) Jul 27, 2026 | Coronavirus, Lung Cancer Scientists from Celloram Inc, University Hospitals, and Case Western Reserve University developed a cancer vaccine platform that repurposes immune memory from COVID-19 to target tumors, according to a study published in Nature Communications. The platform, known…...
Potential new targeted treatment option for people with localised high-risk prostate cancer
14+ hour, 39+ min ago (207+ words) Medical Independent - widget.sndcdn.com 1 sc_anonymous_idUsed in context with the 3D-view-function on the website. Maximum Storage Duration: 10 yearsType: HTTP Cookie - www.medicalindependent.ie 3 ppwp_wp_sessionPreserves users states across page requests. Maximum Storage Duration: 1 dayType: HTTP Cookie webdraw_ipPending Maximum Storage Duration: 30 daysType: HTTP Cookie webdraw_postsPending Maximum…...
HealthCast: Experimental drug daraxonrasib gives some pancreatic patients hope
9+ hour, 14+ min ago (257+ words) Pair of candidates running for Broward County School Board District 1 seat July 27 Tropical Update In mid-December, former U.S. Senator Ben Sasse was diagnosed with one of the most lethal types of cancers. Sasse, 54, received treatment for stage-four pancreatic cancer at the…...
Health Beat: Daraxonrasib provides hope for patients at Nebraska cancer center
14+ hour, 11+ min ago (289+ words) Partly cloudy and muggier with a few evening showers and t-storms, then drier overnight.. headline: Flash Flood Warning from MON 3:58 PM EDT until MON 8:00 PM EDT headline: Severe Thunderstorm Warning from MON 5:51 PM EDT until MON 6:30 PM EDT headline: Flash…...
D&D Pharmatechs' zabopegdutide shows rapid, weight-loss-independent MASH benefit
21+ hour, 51+ min ago (574+ words) D&D Pharmatechs’ zabopegdutide shows rapid, weight-loss-independent MASH benefit Clinical Trials Arena D&D Pharmaceuticals, a South Korean clinical-stage biopharmaceutical company focused on developing medicines for metabolic, fibrotic, and neurodegenerative diseases, has recently published new data from its ongoing Phase…...
First patient enrolled in GOG-3132/BEHOLD-Ovarian01 phase 3 study evaluating Mocertatug Rezetecan, a novel B7-H4–targeted ADC, in platinum-resistant ovarian cancer
17+ hour, 5+ min ago (505+ words) Credit: The GOG Foundation, Inc. 2Porter JM, et al. Antibody drug conjugate targets are highly differentially expressed across the major types of ovarian cancer. European Journal of Cancer. 2025; 224:115522. BEHOLD-Ovarian01 is the first of five planned global Phase 3 studies evaluating mocertatug rezetecan…...
Janice Cowden: Ensuring Patients Have Transparent Information Is as Important as Developing the Next Breakthrough Therapy
16+ hour, 28+ min ago (135+ words) Janice Cowden, MBC Patient Advocate, shared on LinkedIn: “Honored to have contributed as a co-author on this newly published White Paper in Clinical Pharmacology and Therapeutics examining how prescription drug information is generated, communicated, and interpreted. Over the past decade,…...
Scientists Harness COVID-19 Immune Memory to Fight Cancer
12+ hour, 27+ min ago (407+ words) Researchers from Celloram Inc., University Hospitals, and Case Western Reserve University report PROTEXI, a dendritic-cell vaccine platform that repurposes the immune memory created by SARS‑CoV‑2 infection and COVID‑19 vaccination to enhance anti-tumor responses....
mRNA nanogels give prostate tumours a metabolic makeover
17+ hour, 17+ min ago (186+ words) By pairing a prostate-targeted nanogel with mRNA encoding a master regulator of cellular metabolism, researchers have suppressed prostate cancer growth in mice, highlighting a promising new approach for precision RNA therapeutics. PGC1α is often described as the cell’s mitochondrial master regulator,…...
Phase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient
18+ hour, 25+ min ago (94+ words) BEHOLD-Ovarian01 is the first of five planned global Phase 3 studies evaluating mocertatug rezetecan across ovarian and endometrial cancers. These studies comprise the BEHOLD clinical development program, a broad effort designed to evaluate the potential role of B7-H4–targeted therapy across multiple…...